Deep knowledge on small-molecule drugs

How our clients use DrugPatentWatch

pharmaceutical portfolio management

Global FTO Analysis

Specialty Pharmaceuticals and Generics

Identify market entry opportunities and inform portfolio management decisions

Branded Pharmaceutical Manufacturers

Assess past successes of patent challengers and elucidate research paths of competitors

Email Alerts

Set up watchlists for daily email updates

pharmaceutical forecasting

Forecasting

Discover Future Therapeutic Indications

Clinical trials listings and pending patent applications

Formulary Management

Anticipate future budget requirements and proactively identify generic sources

Identify First Generic Entrants

Tentative approvals and Paragraph IV listings

identify generic sources

Business Intelligence

Find Prior Art

Abandoned patent applications and expired patents

Buyers, Wholesalers, and Distributors

Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs

API Manufacturers

Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers

international drug patents and SPCs

Global Coverage

Drug patents and clinical trials in dozens of countries

European Supplementary Protection Certificates


Keep Your Data

Export data to Excel or CSV
 

Global Coverage

Patents in 130+ countries
Supplementary Protection Certificates

Intuitive Interface

Quickly filter and sort results
 

Email Alerts

Get daily updates
 

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Serving International Clients Throughout the Biopharmaceutical Value Chain

Trusted by Industry Leaders

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Fortune- Generics' new legal attack: Big Pharma's aging patents CNN Money - Generics' new legal attack: Big Pharma's aging patents New England Journal of Medicine Barrons

Globalization of Pharmaceutical Drug Innovation The structure and business of biopharmaceutical companies including the management of risks and resources Drug Topics Nature Biotechnology Business Insider National Bureau of Economic Research

International drug patents, API sources, and clinical trials

1,291,251
Patent Applications

116,783
Granted Patents

133
Countries

259,363
Bulk API Sources

108,445
Clinical Trials

For more information try a trial or see the database preview and plans and pricing

Follow DrugPatentWatch:



Google
Twitter
Google Plus
`abc